PepGen (PEPG) News Today $5.13 +0.05 (+0.98%) Closing price 10/3/2025 04:00 PM EasternExtended Trading$5.12 -0.01 (-0.19%) As of 10/3/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Why Is PepGen Up Today?Toggle Visibility of Why Is PepGen Up Today?PepGen, Inc. (NASDAQ:PEPG) shares are trading higher following a mix of positive analyst revisions, insider buying and upcoming clinical presentations. Investors are responding to upbeat guidance from Wedbush on future earnings, a substantial insider purchase, and news of oral presentations at the World Muscle Society Congress. Positive Sentiment: Major shareholder Science Enterprises Plc Oxford picked up 200,000 PepGen shares at an average price of $3.20, boosting its stake by 4.2% and signaling confidence in the company’s outlook. Insider Buy Alert Positive Sentiment: Wedbush reiterated an “Outperform” rating and a $9.00 target, while raising EPS forecasts across most upcoming periods—from FY2025 through FY2029 and each quarter of 2026—reflecting improved profitability expectations. Neutral Sentiment: PepGen will present oral data at the 30th Annual International Congress of the World Muscle Society, offering visibility into its oligonucleotide therapies in neuromuscular disease.Yahoo Finance Article Negative Sentiment: Wedbush trimmed its Q3 2025 EPS forecast to ($0.75) from ($0.73), reflecting a near-term drag on profitability before later periods improve. MarketBeat Alert Posted 1+ days agoAI Generated. May Contain Errors. PEPG Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Wedbush Predicts PepGen's Q3 Earnings (NASDAQ:PEPG)October 4 at 2:19 AM | americanbankingnews.comPepGen Announces Oral Presentations at the 30th Annual International Congress of the World Muscle SocietyOctober 2 at 10:57 PM | finance.yahoo.comPepGen Inc.: PepGen Announces Oral Presentations at the 30th Annual International Congress of the World Muscle SocietyOctober 2 at 5:57 PM | finanznachrichten.deWedbush Issues Negative Outlook for PepGen EarningsOctober 2 at 7:31 AM | marketbeat.comPepGen (NASDAQ:PEPG) Major Shareholder Science Enterprises Plc Oxford Buys 200,000 SharesOctober 2 at 5:35 AM | insidertrades.comScience Enterprises Plc Oxford Purchases 200,000 Shares of PepGen (NASDAQ:PEPG) StockOctober 1, 2025 | marketbeat.comRA Capital discloses increased PepGen stake at 29%October 1, 2025 | msn.comPepGen (PEPG) Price Target Increased by 21.95% to 8.50October 1, 2025 | msn.comPepGen, Inc. $PEPG Shares Sold by Goldman Sachs Group Inc.October 1, 2025 | marketbeat.comPepGen Inc. (PEPG) Rating Upgraded With 135% Upside on FREEDOM DataSeptember 30, 2025 | insidermonkey.comWhat is Wedbush's Estimate for PepGen FY2028 Earnings?September 29, 2025 | marketbeat.comBrokerages Set PepGen, Inc. (NASDAQ:PEPG) Price Target at $8.40September 28, 2025 | americanbankingnews.comPepGen (NASDAQ:PEPG) Price Target Raised to $9.00 at WedbushSeptember 27, 2025 | americanbankingnews.comPepGen (NASDAQ:PEPG) Stock Price Expected to Rise, HC Wainwright Analyst SaysSeptember 27, 2025 | americanbankingnews.comPepGen Announces Closing of Underwritten Public Offering of Common Stock and Exercise in Full of the Underwriters’ Option to Purchase Additional SharesSeptember 26, 2025 | finance.yahoo.comPepGen’s stock up 120% on DM1 trial successSeptember 26, 2025 | msn.comPepGen Announces Closing of Underwritten Public Offering of Common Stock and Exercise in Full of the Underwriters' Option to Purchase Additional SharesSeptember 26, 2025 | businesswire.comPepGen (NASDAQ:PEPG) Price Target Raised to $12.00 at Stifel NicolausSeptember 26, 2025 | americanbankingnews.comWhy Is PepGen Stock (PEPG) Up 125% Today?September 25, 2025 | msn.comPepGen, Inc. (NASDAQ:PEPG) Receives Average Rating of "Moderate Buy" from AnalystsSeptember 25, 2025 | marketbeat.comPepGen (NASDAQ:PEPG) Given New $12.00 Price Target at Stifel NicolausSeptember 25, 2025 | marketbeat.comTop Biotech Stocks To Watch Today - September 25thSeptember 25, 2025 | marketbeat.comPepGen stock soars after reporting highest splicing correction in DM1 patientsSeptember 25, 2025 | za.investing.comPepGen Stock More Than Doubles On Thursday – Check Out The New Price Targets On Wall StreetSeptember 25, 2025 | msn.comPepGen Shares Skyrocket After Record DM1 Splicing Correction ResultsSeptember 25, 2025 | msn.comPepGen Reports Highest Splicing Correction In Dystrophy Patients, Stock DoublesSeptember 25, 2025 | benzinga.comWedbush Forecasts Strong Price Appreciation for PepGen (NASDAQ:PEPG) StockSeptember 25, 2025 | marketbeat.comPepGen (NASDAQ:PEPG) Price Target Raised to $12.00 at HC WainwrightSeptember 25, 2025 | marketbeat.comPepGen's (PEPG) "Buy" Rating Reaffirmed at GuggenheimSeptember 25, 2025 | americanbankingnews.comPepGen Announces Pricing of $100 Million Public OfferingSeptember 24, 2025 | businesswire.comPepGen Announces Proposed Public OfferingSeptember 24, 2025 | businesswire.comPepGen Announces Highest Mean Splicing Correction Reported in DM1 PatientsSeptember 24, 2025 | businesswire.comPepGen's (PEPG) Buy Rating Reiterated at GuggenheimSeptember 24, 2025 | marketbeat.comCan PepGen (NASDAQ:PEPG) Afford To Invest In Growth?September 22, 2025 | finance.yahoo.comKuehn Law Encourages Investors of PepGen Inc. to Contact Law FirmSeptember 19, 2025 | prnewswire.comGuggenheim Initiates Coverage of PepGen (PEPG) with Buy RecommendationSeptember 10, 2025 | msn.comPepGen initiated with a Buy at GuggenheimSeptember 9, 2025 | msn.comFINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of PepGenAugust 11, 2025 | businesswire.comFaruqi & Faruqi Reminds PepGen Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 11, 2025 - PEPGAugust 9, 2025 | prnewswire.comLevi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of PepGen Inc.(PEPG) ShareholdersAugust 8, 2025 | globenewswire.comPepGen Reports Second Quarter 2025 Financial Results and Recent Corporate HighlightsAugust 8, 2025 | finance.yahoo.comPepGen Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before August 8, 2025 to Discuss Your Rights - PEPGAugust 8, 2025 | prnewswire.comPEPGEN (PEPG) FINAL DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds PepGen Investors of the August 8th Deadline and Encourages Investors to Contact the FirmAugust 7, 2025 | globenewswire.comLost Money on PepGen Inc. (PEPG)? Join Class Action Suit Seeking Recovery – Contact The Gross Law FirmAugust 7, 2025 | globenewswire.comPepGen Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. August 8, 2025 Deadline to file Lead Plaintiff Motion.August 7, 2025 | globenewswire.comPEPG INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that PepGen Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitAugust 7, 2025 | globenewswire.comPEPG Investors Have Opportunity to Lead PepGen Inc. Securities Fraud Lawsuit with the Schall Law FirmAugust 7, 2025 | prnewswire.comPEPG DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages PepGen Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 8 Deadline in Securities Class Action – PEPGAugust 6, 2025 | globenewswire.comPomerantz Law Firm Announces the Filing of a Class Action Against PepGen Inc. and Certain Officers - PEPGAugust 6, 2025 | prnewswire.comPEPGEN (PEPG) URGENT DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds PepGen Investors of the August 8th Deadline and Encourages Investors to Contact the FirmAugust 5, 2025 | globenewswire.com Get PepGen News Delivered to You Automatically Sign up to receive the latest news and ratings for PEPG and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PEPG Media Mentions By Week PEPG Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PEPG News Sentiment▼0.770.54▲Average Medical News Sentiment PEPG News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PEPG Articles This Week▼246▲PEPG Articles Average Week Get the Latest News and Ratings for PEPG and Related Stocks Enter your email address to receive the latest news and analysts' ratings for PepGen and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies AnaptysBio News Palvella Therapeutics News MeiraGTx News Siga Technologies News Olema Pharmaceuticals News Keros Therapeutics News Bicara Therapeutics News KalVista Pharmaceuticals News Gossamer Bio News SNDL News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PEPG) was last updated on 10/5/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredU.S. Government Sparking Crypto RallyU.S. Puts GDP on the Blockchain Could this spark the next crypto supercycle? Discover the altcoins poised t...Crypto 101 Media | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredMelt-up warning Porter Stansberry says this bull market is past the “safe zone” and racing toward an event horizon — and in hi...Porter & Company | SponsoredThe Coin That Could Define Trump’s Crypto PresidencyWhen Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top ad...Weiss Ratings | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PepGen, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PepGen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
